Skip to main content
Fig. 5 | BMC Pulmonary Medicine

Fig. 5

From: Probiotic in the prevention of ventilator-associated pneumonia in critically ill patients: evidence from meta-analysis and trial sequential analysis of randomized clinical trials

Fig. 5

Trial sequential analysis for effects of probiotics on VAP incidence in adult patients. The required information size of 6077 was calculated based on the VAP incidence of 20.69, 25.27% in the probiotic and placebo group, respectively (α = 5%, β = 20%, I2 = 56.40%)

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us